Disease | FANTOM ID | DDBJ accession | Gene name | Disease relationship | OMIM status |
---|---|---|---|---|---|
CANCER | |||||
Diagnosis | |||||
1110013A16* | AK003650 | Squamous cell carcinoma antigen 2 | Squamous cell carcinoma | 1 | |
1300012C15* | AK004970 | Cargo selection protein tip47 | Gynecologic malignancies | 2 | |
1600002M22* | AK005400 | Pregnancy-specific beta 1-glycoprotein | Trophoblastic disease, tumour marker | 1 | |
1810011L16* | AK007436 | Adamts-9 precursor | Hereditary renal tumors | 3 | |
2310046E09 | AK009843 | Pancreatic secretory granule membrane major glycoprotein gp2 precursor | Chronic lymphocytic leukemia | 2 | |
2600013I19* | AK011199 | Diphthamide biosynthesis protein-2 | Prognosis of neoplastic diseases | 2 | |
4631401E18* | AK019470 | Udp-n-acetyl-alpha-d-galactosamine:polypeptide n-acetylgalactosaminyl Transferase 7 | Colorectal carcinoma | 2 | |
4930435F02 | AK019597 | 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Breast cancer | 3 | |
4932411D20* | AK029960 | Ctcl tumor antigen se2-2 | T-cell based immunotherapy | 3 | |
5330423N11* | AK077331 | Melastatin 2 | Cutaneous malignant melanoma | 3 | |
9130023H10* | AK033603 | Mlze | Melanoma | 3 | |
9130413M24* | AK078964 | Ctcl tumor antigen se57-1 | T-cell based immunotherapy | 3 | |
9330156N18* | AK034104 | Desmoglein 1 precursor | Paraneoplastic pemphigus | 2 | |
A030012E10* | AK037235 | Serine protease desc1 precursor | Squamous cell carcinoma | 3 | |
A230060D07* | AK038754 | Reverse transcriptase-like protein | Chronic myelogenous leukemia | 3 | |
A430037M23 | AK039975 | Dipeptidyl-peptidase iii | Endometrial neoplasms | 2 | |
A630051G17 | AK080312 | Meningioma-expressed antigen 6/11 | Meningioma and glioma | 1 | |
E130307D12* | AK087504 | Scaffold attachment Factor b | Breast cancer | 1 | |
G430124K07* | AK090101 | Restricted expression proliferation associated protein 100 | Lung carcinoma | 3 | |
Pathophysiology | |||||
0610006O14 | AK002260 | Vacuolar proton-atpase subunit atp6h | Melanoma | 2 | |
0610008P16* | AK002360 | Hp33 protein | Hepatocellular carcinoma | 3 | |
1110068E08* | AK004405 | Ku70-binding protein | Gliomas | 3 | |
1200003O15* | AK004587 | Proto-oncogene tyrosine-protein kinase fes/fps | Leukaemia | 1 | |
1500012D09 | AK005230 | Ras-related protein rab-2 | Nasopharyngeal carcinoma | 1 | |
1700001P03* | AK005620 | Homeobox transcription factor | Colon cancer | 1 | |
1700006L01 | Smac protein, mitochondrial precursor | Multiple myeloma | 2 | ||
1700012B18* | AK005892 | Pregnancy-induced growth inhibitor | Breast cancer | 3 | |
1700045I19* | AK006700 | Hsd-4 protein | Prostate cancer | 2 | |
1810017F10* | AK007525 | Beta-casein-like protein | Tumour-associated antigen | 3 | |
2010003F10* | AK008064 | Transmembrane 4 superfamily, member 5 | Pancreatic cancer | 1 | |
2210006M16* | AK008663 | Gasdermin | Human gastric cancer cells | 3 | |
2210007N23 | AK019050 | Ca11 protein homolog | Gastric carcinogenesis | 1 | |
2210412D05 | AK008907 | Rho guanine nucleotide exchange factor 5 | Acute myeloid leukaemia | 1 | |
2210414K06 | AK008928 | Nesh | Cell metastasis and malignant transformation | 2 | |
2310016C08* | AK009377 | Hypoxia-inducible protein 2 | Cervix cancer | 3 | |
2510002J07* | AK010891 | 1-acyl-sn-glycerol-3-phosphate acyltransferase beta | Cancers and inflammation-associated diseases. | 2 | |
2610002I10 | AK011289 | C-myc target jpo1 | Tumourigenesis | 3 | |
2610005L07 | AK011323 | Cadherin | Cancer development | 1 | |
2700048G21* | AK012392 | Antigen ny-co-8 | Colon cancer antigen | 3 | |
2810411G23 | AK013085 | Tumor protein d54 | Breast cancer | 1 | |
2810425C21* | AK013153 | Death domain of death-associated protein kinase 1 | Non-small cell lung cancer | 2 | |
2810449N18* | AK013316 | Sirtuin 6 | Thyroid carcinoma | 2 | |
2900009D12 | AK013503 | Succinate dehydrogenase | Hereditary paraganglioma | 1 | |
4432412E01* | AK014491 | X-ray repair cross-complementing protein 3 | Bladder-cancer | 2 | |
4631410F01 | AK028459 | Adamts-12 precursor | Gastric carcinomas | 3 | |
4732440A06* | AK028704 | Calcium-activated chloride channel-2 | Breast cancer, metastasis | 2 | |
4930500E24* | AK019661 | Gas-2 related protein on chromosome 22 | Central nervous system tumours | 3 | |
4932436B18* | AK030081 | Pms1 protein homolog 1 | Prostate cancer | 1 | |
4933405E14* | AK016662 | Serologically defined colon cancer antigen 1 | Tumour suppressor | 3 | |
4933409E02* | AK016751 | Retinoblastoma-associated protein rap140 | Colon cancer cell line | 3 | |
5430417G24* | AK030670 | Headpin serine proteinase inhibitor | Squamous cell carcinoma | 1 | |
5630400A09* | AK030708 | P63 protein | Basal cell and squamous cell carcinomas | 1 | |
5730484M20* | AK077629 | Cell cycle checkpoint protein chfr | Lung cancer | 1 | |
6430531D06* | AK032385 | Elks | Capillary thyroid carcinoma | 1 | |
6430587E11 | AK032541 | Copine vii | Breast cancer | 1 | |
6820401K01* | AK033012 | Npat | Cancer development | 2 | |
9330137N20 | AK079068 | Hepatic leukemia factor | Lymphoblastic leukaemia | 1 | |
9330200A01* | AK034492 | Ubiquitin specific protease | Squamous non-small cell lung carcinoma | 2 | |
A130080E24* | AK038118 | C-myb protein | Colon tumour | 3 | |
A430025E01* | AK039888 | P68 RNA helicase | Colorectal tumours | 2 | |
A430075F05 | AK040185 | Lipoma preferred partner | Acute myeloid leukaemia | 1 | |
A730042E07 | AK042943 | Serine/threonine protein phosphatase 2a, 72/130 kda regulatory subunit B | Melanoma | 2 | |
A830098D13* | AK044188 | Megacaryocytic acute leukemia protein, isoform i | Acute megakaryoblastic leukemias | 1 | |
A930033B01 | AK020920 | Graf | Hematopoeitic disorders | 1 | |
B130017M24 | AK044984 | Hepatocellular carcinoma autoantigen | Hepatocellular carcinoma | 3 | |
B230314N17 | AK045848 | Deleted in lung and esophageal cancer 1 | Carcinogenesis | 1 | |
B930026D14* | AK047144 | Myc box dependent interacting protein 1 | Prostate carcinoma | 3 | |
B930095M03* | AK081171 | Frat2 | Gastric cancer | 1 | |
C130050F24* | AK048341 | Ranbp7/importin 7 | Colorectal carcinoma | 2 | |
C130062I06* | AK048462 | Fibrillarin | Hepatocellular carcinoma | 1 | |
C230012L01 | AK048706 | Androgen-induced prostate proliferative shutoff associated protein | Prostate cancer | 1 | |
C630001O15 | AK049821 | Malt1 | MALT lymphoma | 1 | |
D330038I09 | AK052361 | 10-formyltetrahydrofolate dehydrogenase | Tumour cells | 2 | |
E030001H09* | AK086788 | Phd finger protein 3 | Glioblastoma multiforme | 1 | |
E030027H19* | AK087108 | Cub domain containing Protein 1 | Human colorectal cancer | 3 | |
E230037B21 | AK054229 | Vault poly(adp-ribose) polymerase | Several tumour types | 3 | |
F630110I03 | AK089273 | Matrix metalloproteinase-25 precursor | Colon carcinomas or brain tumours | 3 | |
F730035A01 | AK089461 | Swi/snf complex 170 kda subunit | Malignant rhabdoid tumours | 1 | |
G630018E19* | AK090207 | Prostate cancer overexpressed gene 1 | Prostate cancer | 1 | |
G630034H08* | AK090280 | Transcriptional repressor scratch | Small cell lung cancer | 3 | |
Treatment | |||||
1100001P14 | AK075618 | Beta-tubulin class iva isotype | Human colon adenocarcinoma | 3 | |
1200012D01* | AK004723 | Magic roundabout | Angiogenesis | 3 | |
1810010L20 | AK075773 | Pituitary tumor-transforming gene 1 protein-interacting protein | Pituitary adenomas | 2 | |
2310039D24* | AK009689 | Carboxylesterase | Solid tumours | 1 | |
2600009M07 | AK011174 | Polyamine modulated factor-1 | Antineoplastic activity | 3 | |
2810459H04 | AK013366 | Thrombospondin | Angiogenesis | 1 | |
3010033I09* | AK019405 | Alex1 | Tumours originating from epithelial tissue | 1 | |
5730405M22* | AK077421 | Phosphoprotein enriched in astrocytes 15 | Glioma | 2 | |
6030493E19 | AK031701 | Melanoma antigen p15 | Melanoma | 1 | |
6230424I22* | AK031785 | NUCLEAR MATRIX PROTEIN p84 | Tumor suppression | 2 | |
A730016J02 | AK042696 | Acetyltransferase tubedown-1 | Vascular and haematopoietic development | 3 | |
B130023J22 | AK045057 | Greb1b | Breast cancer | 3 | |
C920008O22 | AK050594 | Retinoblastoma-binding protein 1 | Breast cancer | 2 | |
D030050C19 | AK083587 | Chronic myelogenous leukemia tumor antigen 66 | Leukemias and tumour cell lines | 1 | |
D630010E08* | AK052639 | Carbonic anhydrase xii precursor | Cancer tumour cells | 1 | |
D830007E07* | AK052857 | Inositol hexakisphosphate kinase 3 | Ovarian cancer | 2 |